China National Accord Medicines (SZSE:000028) 3-Year Revenue Growth Rate : 8.20% (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines 3-Year Revenue Growth Rate?

China National Accord Medicines's Revenue per Share for the three months ended in Mar. 2024 was ¥34.37.

During the past 12 months, China National Accord Medicines's average Revenue per Share Growth Rate was 1.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 8.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of China National Accord Medicines was 174.60% per year. The lowest was -18.20% per year. And the median was 12.60% per year.

Competitive Comparison of China National Accord Medicines's 3-Year Revenue Growth Rate

For the Medical Distribution subindustry, China National Accord Medicines's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China National Accord Medicines's 3-Year Revenue Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's 3-Year Revenue Growth Rate falls into.

China National Accord Medicines 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

China National Accord Medicines (SZSE:000028) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

China National Accord Medicines 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines